
Elucidata Expands Leadership Team with AI and Biotech Experts
Key Highlights:
- Elucidata appoints Dr. Werner Lanthaler as Independent Board Member and Dr. Navjot Singh as Advisor.
- Recognized as Fast Company’s Most Innovative Biotech Company and winner of National Cancer Institute's AI-Readiness Challenge.
- Dr. Lanthaler brings biotech leadership and innovation expertise from Evotec SE and Wlanholding.
- Dr. Singh, a Senior Partner Emeritus at McKinsey & Co., specializes in AI, healthcare, and digital transformation.
- Elucidata advances AI-ready data solutions, ensuring data quality as a service for biopharma R&D.
Source: Business Wire
Quotes
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.



